M. Tsiatas – Beyond PD-L1: Biomarkers of immunotherapy efficacy
E. K. Vetsika – Small extracellular vesicles in pre-therapy plasma predict clinical outcome in …
N. Pistamaltzian – Immunotherapy in oncogene-addicted lung cancer
M. Tsoukamakidou – Proteomic screening of bronchoscopic biopsies-on-chip for improved prediction …
A. Xagara – B-PREIMMUNE (Blood derived pre-immune platform) project
M. Toki – Discovery and quantitative measurement of biomarkers in Tumor Microenvironment
P. Verginis – Resistance mechanism of immunotherapy: the role of T cells
F. I. Dimitrakopoulos – NF-κB & NSCLC: clinical perspectives
I. Vathiotis – CD200/CD200R Immune Checkpoint in Lung Cancer
V. Papadimitrakopoulou – Mechanisms of resistance to checkpoint inhibitors and targeting …
A. Agbarya – Kinase signaling networks in SCLC
P. Tsantoulis – When EGFR is not alone
A. Georgiou – Phosphoproteomics and functional genomics to investigate resistance mechanisms …
A. Patrikidou – Overview of early phase clinical research with a focus on thoracic oncology
M. Jamal Hanjani – Lung cancer evolution and its clinical implications
